Literature DB >> 8411012

Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol.

K Thakkar1, R L Geahlen, M Cushman.   

Abstract

A series of hydroxylated trans-stilbenes related to the antileukemic natural product trans-3,3',4,5'-tetrahydroxystilbene (piceatannol) (1) has been prepared and tested for inhibition of the lymphoid cell lineage-specific protein-tyrosine kinase p56lck, which plays an important role in lymphocyte proliferation and immune function. A number of the analogues displayed enhanced enzyme inhibitory activity relative to the natural product. Reduction of the double bond bridging the two aromatic rings and benzylation of the phenolic hydroxyl groups was found to decrease activity significantly. The most potent compounds in the series proved to be trans-3,3',5,5'-tetrahydroxystilbene, trans-3,3',5-trihydroxystilbene, and trans-3,4,4'-trihydroxystilbene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411012     DOI: 10.1021/jm00072a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  Resveratrol and resveratrol analogues--structure-activity relationship.

Authors:  Thomas Szekeres; Monika Fritzer-Szekeres; Philipp Saiko; Walter Jäger
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

2.  Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers.

Authors:  Daniel P Flaherty; Tomomi Kiyota; Yuxiang Dong; Tsuneya Ikezu; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2010-11-01       Impact factor: 7.446

3.  Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation.

Authors:  Jung Yeon Kwon; Sang Gwon Seo; Yong-Seok Heo; Shuhua Yue; Ji-Xin Cheng; Ki Won Lee; Kee-Hong Kim
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

4.  The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy.

Authors:  Li-Man Hung; Ming-Jai Su; Wing-Keung Chu; Chin-Wei Chiao; Wan-Fen Chan; Jan-Kan Chen
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 5.  Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells.

Authors:  Mary Jo Atten; Ernesto Godoy-Romero; Bashar M Attar; Thomas Milson; Matthew Zopel; Oksana Holian
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

6.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

7.  The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

Authors:  G A Potter; L H Patterson; E Wanogho; P J Perry; P C Butler; T Ijaz; K C Ruparelia; J H Lamb; P B Farmer; L A Stanley; M D Burke
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

8.  The 4'-hydroxyl group of resveratrol is functionally important for direct activation of PPARα.

Authors:  Yoshie Takizawa; Rieko Nakata; Kiyoshi Fukuhara; Hiroshi Yamashita; Hideo Kubodera; Hiroyasu Inoue
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Production of highly bioactive resveratrol analogues pterostilbene and piceatannol in metabolically engineered grapevine cell cultures.

Authors:  Ascensión Martínez-Márquez; Jaime A Morante-Carriel; Karla Ramírez-Estrada; Rosa M Cusidó; Javier Palazon; Roque Bru-Martínez
Journal:  Plant Biotechnol J       Date:  2016-03-07       Impact factor: 9.803

10.  Synthesis of new optically active 2-pyrrolidinones.

Authors:  Panagiota Moutevelis-Minakakis; Eleni Papavassilopoulou; Thomas Mavromoustakos
Journal:  Molecules       Date:  2012-12-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.